
Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development
Betsy Goodfellow | March 15, 2024 | News story | Research and Development | Allumiqs, Pharmacy, drug discovery, partnership
Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve and integrated solutions for their customers to optimise drug development pipelines.
The two companies intend for this partnership to ‘empower customers with bikoanalytical solutions to advance drug candidates from early R&D phases through to lot release’, according to the companies’ press release.
It is planned that Allumiqs will provide biological insights and therapeutic characterisation in the early stages of a customer’s R&D work, before Prolytix will take over and offer targeted method development for stability, potency and GMP release testing. These interconnected solutions and processes are the main aim of the collaboration.
Kent MacLean, chief executive officer of Allumiqs, commented: “We found many synergies in working with the team at Prolytix in collaborative customer projects, most importantly our shared commitment to customer success. Now in partnership with Prolytix we can take all of our customers further in the drug development process with connected solutions from early R&D to lot release. Our goal is to make it simple for our customers to engage with the innovation partners they need at every stage of the drug discovery process, and our partnership with Prolytix does that.”
Betsy Goodfellow
Related Content

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration …

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …

PM Society and CIM launch new leadership programme for pharma marketers
The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to …






